NIOSH dioxin registry site visit report of Givaudan Corporation, Clifton, New Jersey.
Public Domain
-
1990/12/01
Details
-
Personal Author:
-
Description:As part of an investigation of the health effects of exposure to polychlorinated dibenzo-p-dioxins (PCDD) and in particular to 2,3,7,8-tetrachlorodibenzo-p-dioxin (1746016) (TCDD), a visit was made to the Givaudan Corporation, Clifton, New Jersey. The NIOSH Dioxin Registry was designed as a compilation of demographic and work history information for all U.S. production workers who have synthesized products known to have been contaminated with TCDD or hexachlorodibenzo-p-dioxins (HxCCD). This company produced 2,4,5- trichlorophenol (95954) (245T) from 1945 to 1949 and hexachlorophene (70304) from 1945 to 1984. The findings of the visit indicated that workers who were employed in the hexachlorophene department between 1957 and 1984 could be identified and were appropriate for inclusion in the NIOSH dioxin Registry. Prior work in the hexachlorophene department for these individuals cannot be documented. It was not possible to identify hexachlorophene workers employed between 1945 and 1956, workers employed in 245T production from 1945 through 1949 or the maintenance workers who serviced the hexachlorophene or 245T processes during their years of operation.
-
Subjects:
-
Keywords:
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:1-27
-
NIOSHTIC Number:nn:00197973
-
Citation:Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, IWS 117-22, 1990 Dec; :1-27
-
CAS Registry Number:
-
Federal Fiscal Year:1991
-
Peer Reviewed:False
-
Collection(s):
-
Main Document Checksum:urn:sha-512:15a42df28549308326724392d620075eb04c630de101c15d6cd31e38cee01016834d99f43771a73f98187bf774d9bb292733f9fa9bd84545e109079c1f270645
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like